Lowering the cost of drugs is a laudable objective, especially in Florida, which has 4.2 million seniors over the age of 65 and the largest percentage of such residents of any state. Florida policymakers are discussing ways to lower the cost of medicine and Floridians of all ages should be aware of a bill that […]
The enhanced Affordable Care Act subsidies that were at the center of the October government shutdown were not only made available to people making as much as $500,000 annually but also turned out to be rife with waste, fraud, and abuse. A December 3, 2025, Government Accountability Office (GAO) report revealed that the advanced premium […]
The enhanced Affordable Care Act subsidies that were at the center of the October government shutdown were not only made available to people making as much as $500,000 annually but also turned out to be rife with waste, fraud, and abuse. A December 3, 2025, Government Accountability Office (GAO) report revealed that the advanced premium […]
As Americans gather with family and friends to celebrate Thanksgiving, healthcare costs are one of their main concerns. President Trump has made lowering drug prices and increasing domestic biopharmaceutical research and development high priorities in his second term in office. Domestic investment by drug companies has skyrocketed since Eli Lilly was the first company to […]
The United States is the global leader in developing innovative and life-saving cures and treatments thanks to the investments made by pharmaceutical companies in the United States, including the vaccines that helped end the coronavirus pandemic. Vaccines are crucial to the physical and economic health of not just Americans but also people across the rest […]
Welcome to This Week in Waste, a series by Citizens Against Government Waste (CAGW) that highlights how taxpayer dollars are being wasted in the federal, state, and local levels of government and efforts to fight back against this spendthrift behavior. Senate Health, Education, Labor, and Pensions (HELP) Committee Hearing is Next Step for 340B Reform The […]
The 340B Drug Discount Program was given the laudable goal of helping federally funded clinics and public hospitals that serve a large uninsured population cover the cost of drugs and provide discounts to patients. However, like many other well-intended federal programs 340B has gone off the rails due to the lack of clear intent and […]
The establishment of well-intentioned programs that fail to achieve their objectives and waste taxpayer dollars is an unfortunately frequent occurrence in the federal government. A prominent example of such an outcome is the 340B program, created by Section 340B of the Public Health Service Act of 1992, which requires pharmaceutical manufacturers participating in Medicaid to […]
President Trump has made lowering drug prices and reducing healthcare costs for Americans a top priority of his second term, along with encouraging more biopharmaceutical investment and innovation in the U.S. Citizens Against Government Waste suggests that he can achieve both objectives without imposing price controls, which includes Most Favored Nation (MFN) polices, reforming the […]
The 340B Drug Discount Program was created in 1992 and requires pharmaceutical manufacturers participating in Medicaid to sell drugs to “Covered Entities” (CEs), including non-profit hospitals like the Cleveland Clinic, at discounts of 20 to 50 percent. The program grew from $9 billion in 2014 to $66 billion in 2023, making it the second-largest federal […]
